カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

一般用医薬品の世界市場2025年：先発医薬品、ジェネリック医薬品

■ 英語タイトル：Global Non-prescription Drugs Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22DC3872）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22DC3872
■ 発行日：2025年3月
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：129
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥515,040見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥772,560見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,030,080見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[一般用医薬品の世界市場2025年：先発医薬品、ジェネリック医薬品]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

世界の一般用医薬品市場レポートは、グローバル市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
Global Info Research社の最新のリサーチによると、世界の一般用医薬品の市場規模は2024年のxxx米ドルから2031年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

一般用医薬品市場はタイプとアプリケーションによって区分されます。2020年～2031年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

タイプ別セグメントは次をカバーします。
・先発医薬品、ジェネリック医薬品

アプリケーション別セグメントは次のように区分されます。
・病院、診療所、その他

世界の一般用医薬品市場の主要な市場プレーヤーは以下のとおりです。
・Pfizer、Roche、Sanofi、Johnson & Johnson、Merck & Co. (MSD)、Novartis、AbbVie、Gilead Sciences、GlaxoSmithKline (GSK)、Amgen、AstraZeneca、Bristol-Myers Squibb、Eli Lilly、Teva、Bayer、Novo Nordisk、Allergan、Takeda、Boehringer Ingelheim、Takeda

地域別セグメントは次の地域・国をカバーします。
・北米（アメリカ、カナダ、メキシコ）
・欧州（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南米（ブラジル、アルゼンチン、コロンビア）
・中東/アフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査資料の内容は計15章あります。
・第1章では、一般用医薬品製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な一般用医薬品メーカーの企業概要、2022年～2024年までの一般用医薬品の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な一般用医薬品メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2020年～2031年までの地域別一般用医薬品の販売量、売上、成長性を示しています。
・第5、6章では、2020年～2031年までの一般用医薬品の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2020年～2024年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での一般用医薬品市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および一般用医薬品の産業チェーンを掲載しています。
・第13、14、15章では、一般用医薬品の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
– 一般用医薬品の概要
– 種類別分析（2020年vs2024年vs2031年）：先発医薬品、ジェネリック医薬品
– 用途別分析（2020年vs2024年vs2031年）：病院、診療所、その他
– 世界の一般用医薬品市場規模・予測
– 世界の一般用医薬品生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Pfizer、Roche、Sanofi、Johnson & Johnson、Merck & Co. (MSD)、Novartis、AbbVie、Gilead Sciences、GlaxoSmithKline (GSK)、Amgen、AstraZeneca、Bristol-Myers Squibb、Eli Lilly、Teva、Bayer、Novo Nordisk、Allergan、Takeda、Boehringer Ingelheim、Takeda
・メーカー別市場シェア・市場集中度
・地域別市場分析2020年-2031年
・種類別分析2020年-2031年：先発医薬品、ジェネリック医薬品
・用途別分析2020年-2031年：病院、診療所、その他
・一般用医薬品の北米市場
– 種類別市場規模2020年-2031年
– 用途別市場規模2020年-2031年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・一般用医薬品のヨーロッパ市場
– 種類別市場規模2020年-2031年
– 用途別市場規模2020年-2031年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・一般用医薬品のアジア市場
– 種類別市場規模2020年-2031年
– 用途別市場規模2020年-2031年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・一般用医薬品の南米市場
– 種類別市場規模2020年-2031年
– 用途別市場規模2020年-2031年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・一般用医薬品の中東・アフリカ市場
– 種類別市場規模2020年-2031年
– 用途別市場規模2020年-2031年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Non-prescription Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Non-prescription Drugs Revenue by Type: 2020 Versus 2024 Versus 2031
1.2.2 Brand Drugs
1.2.3 Generic Drug
1.3 Market Analysis by Application
1.3.1 Overview: Global Non-prescription Drugs Revenue by Application: 2020 Versus 2024 Versus 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Non-prescription Drugs Market Size & Forecast
1.4.1 Global Non-prescription Drugs Sales in Value (2020 & 2024 & 2031)
1.4.2 Global Non-prescription Drugs Sales in Volume (2020-2031)
1.4.3 Global Non-prescription Drugs Price (2020-2031)
1.5 Global Non-prescription Drugs Production Capacity Analysis
1.5.1 Global Non-prescription Drugs Total Production Capacity (2020-2031)
1.5.2 Global Non-prescription Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Non-prescription Drugs Market Drivers
1.6.2 Non-prescription Drugs Market Restraints
1.6.3 Non-prescription Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Non-prescription Drugs Product and Services
2.1.4 Pfizer Non-prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2021, 2022, 2023, and 2024)
2.2 Roche
2.2.1 Roche Details
2.2.2 Roche Major Business
2.2.3 Roche Non-prescription Drugs Product and Services
2.2.4 Roche Non-prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2021, 2022, 2023, and 2024)
2.3 Sanofi
2.3.1 Sanofi Details
2.3.2 Sanofi Major Business
2.3.3 Sanofi Non-prescription Drugs Product and Services
2.3.4 Sanofi Non-prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2021, 2022, 2023, and 2024)
2.4 Johnson & Johnson
2.4.1 Johnson & Johnson Details
2.4.2 Johnson & Johnson Major Business
2.4.3 Johnson & Johnson Non-prescription Drugs Product and Services
2.4.4 Johnson & Johnson Non-prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2021, 2022, 2023, and 2024)
2.5 Merck & Co. (MSD)
2.5.1 Merck & Co. (MSD) Details
2.5.2 Merck & Co. (MSD) Major Business
2.5.3 Merck & Co. (MSD) Non-prescription Drugs Product and Services
2.5.4 Merck & Co. (MSD) Non-prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2021, 2022, 2023, and 2024)
2.6 Novartis
2.6.1 Novartis Details
2.6.2 Novartis Major Business
2.6.3 Novartis Non-prescription Drugs Product and Services
2.6.4 Novartis Non-prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2021, 2022, 2023, and 2024)
2.7 AbbVie
2.7.1 AbbVie Details
2.7.2 AbbVie Major Business
2.7.3 AbbVie Non-prescription Drugs Product and Services
2.7.4 AbbVie Non-prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2021, 2022, 2023, and 2024)
2.8 Gilead Sciences
2.8.1 Gilead Sciences Details
2.8.2 Gilead Sciences Major Business
2.8.3 Gilead Sciences Non-prescription Drugs Product and Services
2.8.4 Gilead Sciences Non-prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2021, 2022, 2023, and 2024)
2.9 GlaxoSmithKline (GSK)
2.9.1 GlaxoSmithKline (GSK) Details
2.9.2 GlaxoSmithKline (GSK) Major Business
2.9.3 GlaxoSmithKline (GSK) Non-prescription Drugs Product and Services
2.9.4 GlaxoSmithKline (GSK) Non-prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2021, 2022, 2023, and 2024)
2.10 Amgen
2.10.1 Amgen Details
2.10.2 Amgen Major Business
2.10.3 Amgen Non-prescription Drugs Product and Services
2.10.4 Amgen Non-prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2021, 2022, 2023, and 2024)
2.11 AstraZeneca
2.11.1 AstraZeneca Details
2.11.2 AstraZeneca Major Business
2.11.3 AstraZeneca Non-prescription Drugs Product and Services
2.11.4 AstraZeneca Non-prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2021, 2022, 2023, and 2024)
2.12 Bristol-Myers Squibb
2.12.1 Bristol-Myers Squibb Details
2.12.2 Bristol-Myers Squibb Major Business
2.12.3 Bristol-Myers Squibb Non-prescription Drugs Product and Services
2.12.4 Bristol-Myers Squibb Non-prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2021, 2022, 2023, and 2024)
2.13 Eli Lilly
2.13.1 Eli Lilly Details
2.13.2 Eli Lilly Major Business
2.13.3 Eli Lilly Non-prescription Drugs Product and Services
2.13.4 Eli Lilly Non-prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2021, 2022, 2023, and 2024)
2.14 Teva
2.14.1 Teva Details
2.14.2 Teva Major Business
2.14.3 Teva Non-prescription Drugs Product and Services
2.14.4 Teva Non-prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2021, 2022, 2023, and 2024)
2.15 Bayer
2.15.1 Bayer Details
2.15.2 Bayer Major Business
2.15.3 Bayer Non-prescription Drugs Product and Services
2.15.4 Bayer Non-prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2021, 2022, 2023, and 2024)
2.16 Novo Nordisk
2.16.1 Novo Nordisk Details
2.16.2 Novo Nordisk Major Business
2.16.3 Novo Nordisk Non-prescription Drugs Product and Services
2.16.4 Novo Nordisk Non-prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2021, 2022, 2023, and 2024)
2.17 Allergan
2.17.1 Allergan Details
2.17.2 Allergan Major Business
2.17.3 Allergan Non-prescription Drugs Product and Services
2.17.4 Allergan Non-prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2021, 2022, 2023, and 2024)
2.18 Takeda
2.18.1 Takeda Details
2.18.2 Takeda Major Business
2.18.3 Takeda Non-prescription Drugs Product and Services
2.18.4 Takeda Non-prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2021, 2022, 2023, and 2024)
2.19 Boehringer Ingelheim
2.19.1 Boehringer Ingelheim Details
2.19.2 Boehringer Ingelheim Major Business
2.19.3 Boehringer Ingelheim Non-prescription Drugs Product and Services
2.19.4 Boehringer Ingelheim Non-prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2021, 2022, 2023, and 2024)
2.20 Takeda
2.20.1 Takeda Details
2.20.2 Takeda Major Business
2.20.3 Takeda Non-prescription Drugs Product and Services
2.20.4 Takeda Non-prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2021, 2022, 2023, and 2024)
3 Non-prescription Drugs Breakdown Data by Manufacturer
3.1 Global Non-prescription Drugs Sales in Volume by Manufacturer (2021, 2022, 2023, and 2024)
3.2 Global Non-prescription Drugs Revenue by Manufacturer (2021, 2022, 2023, and 2024)
3.3 Key Manufacturer Market Position in Non-prescription Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Non-prescription Drugs Manufacturer Market Share in 2024
3.4.2 Top 6 Non-prescription Drugs Manufacturer Market Share in 2024
3.5 Global Non-prescription Drugs Production Capacity by Company: 2023 VS 2024
3.6 Manufacturer by Geography: Head Office and Non-prescription Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Non-prescription Drugs Market Size by Region
4.1.1 Global Non-prescription Drugs Sales in Volume by Region (2020-2031)
4.1.2 Global Non-prescription Drugs Revenue by Region (2020-2031)
4.2 North America Non-prescription Drugs Revenue (2020-2031)
4.3 Europe Non-prescription Drugs Revenue (2020-2031)
4.4 Asia-Pacific Non-prescription Drugs Revenue (2020-2031)
4.5 South America Non-prescription Drugs Revenue (2020-2031)
4.6 Middle East and Africa Non-prescription Drugs Revenue (2020-2031)
5 Market Segment by Type
5.1 Global Non-prescription Drugs Sales in Volume by Type (2020-2031)
5.2 Global Non-prescription Drugs Revenue by Type (2020-2031)
5.3 Global Non-prescription Drugs Price by Type (2020-2031)
6 Market Segment by Application
6.1 Global Non-prescription Drugs Sales in Volume by Application (2020-2031)
6.2 Global Non-prescription Drugs Revenue by Application (2020-2031)
6.3 Global Non-prescription Drugs Price by Application (2020-2031)
7 North America by Country, by Type, and by Application
7.1 North America Non-prescription Drugs Sales by Type (2020-2031)
7.2 North America Non-prescription Drugs Sales by Application (2020-2031)
7.3 North America Non-prescription Drugs Market Size by Country
7.3.1 North America Non-prescription Drugs Sales in Volume by Country (2020-2031)
7.3.2 North America Non-prescription Drugs Revenue by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8 Europe by Country, by Type, and by Application
8.1 Europe Non-prescription Drugs Sales by Type (2020-2031)
8.2 Europe Non-prescription Drugs Sales by Application (2020-2031)
8.3 Europe Non-prescription Drugs Market Size by Country
8.3.1 Europe Non-prescription Drugs Sales in Volume by Country (2020-2031)
8.3.2 Europe Non-prescription Drugs Revenue by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Non-prescription Drugs Sales by Type (2020-2031)
9.2 Asia-Pacific Non-prescription Drugs Sales by Application (2020-2031)
9.3 Asia-Pacific Non-prescription Drugs Market Size by Region
9.3.1 Asia-Pacific Non-prescription Drugs Sales in Volume by Region (2020-2031)
9.3.2 Asia-Pacific Non-prescription Drugs Revenue by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10 South America by Region, by Type, and by Application
10.1 South America Non-prescription Drugs Sales by Type (2020-2031)
10.2 South America Non-prescription Drugs Sales by Application (2020-2031)
10.3 South America Non-prescription Drugs Market Size by Country
10.3.1 South America Non-prescription Drugs Sales in Volume by Country (2020-2031)
10.3.2 South America Non-prescription Drugs Revenue by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Non-prescription Drugs Sales by Type (2020-2031)
11.2 Middle East & Africa Non-prescription Drugs Sales by Application (2020-2031)
11.3 Middle East & Africa Non-prescription Drugs Market Size by Country
11.3.1 Middle East & Africa Non-prescription Drugs Sales in Volume by Country (2020-2031)
11.3.2 Middle East & Africa Non-prescription Drugs Revenue by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12 Raw Material and Industry Chain
12.1 Raw Material of Non-prescription Drugs and Key Manufacturers
12.2 Manufacturing Costs Percentage of Non-prescription Drugs
12.3 Non-prescription Drugs Production Process
12.4 Non-prescription Drugs Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Non-prescription Drugs Typical Distributors
13.3 Non-prescription Drugs Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Non-prescription Drugs Revenue by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Non-prescription Drugs Revenue by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Pfizer Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Major Business
Table 5. Pfizer Non-prescription Drugs Product and Services
Table 6. Pfizer Non-prescription Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021, 2022, 2023, and 2024)
Table 7. Roche Basic Information, Manufacturing Base and Competitors
Table 8. Roche Major Business
Table 9. Roche Non-prescription Drugs Product and Services
Table 10. Roche Non-prescription Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021, 2022, 2023, and 2024)
Table 11. Sanofi Basic Information, Manufacturing Base and Competitors
Table 12. Sanofi Major Business
Table 13. Sanofi Non-prescription Drugs Product and Services
Table 14. Sanofi Non-prescription Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021, 2022, 2023, and 2024)
Table 15. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 16. Johnson & Johnson Major Business
Table 17. Johnson & Johnson Non-prescription Drugs Product and Services
Table 18. Johnson & Johnson Non-prescription Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021, 2022, 2023, and 2024)
Table 19. Merck & Co. (MSD) Basic Information, Manufacturing Base and Competitors
Table 20. Merck & Co. (MSD) Major Business
Table 21. Merck & Co. (MSD) Non-prescription Drugs Product and Services
Table 22. Merck & Co. (MSD) Non-prescription Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021, 2022, 2023, and 2024)
Table 23. Novartis Basic Information, Manufacturing Base and Competitors
Table 24. Novartis Major Business
Table 25. Novartis Non-prescription Drugs Product and Services
Table 26. Novartis Non-prescription Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021, 2022, 2023, and 2024)
Table 27. AbbVie Basic Information, Manufacturing Base and Competitors
Table 28. AbbVie Major Business
Table 29. AbbVie Non-prescription Drugs Product and Services
Table 30. AbbVie Non-prescription Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021, 2022, 2023, and 2024)
Table 31. Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table 32. Gilead Sciences Major Business
Table 33. Gilead Sciences Non-prescription Drugs Product and Services
Table 34. Gilead Sciences Non-prescription Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021, 2022, 2023, and 2024)
Table 35. GlaxoSmithKline (GSK) Basic Information, Manufacturing Base and Competitors
Table 36. GlaxoSmithKline (GSK) Major Business
Table 37. GlaxoSmithKline (GSK) Non-prescription Drugs Product and Services
Table 38. GlaxoSmithKline (GSK) Non-prescription Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021, 2022, 2023, and 2024)
Table 39. Amgen Basic Information, Manufacturing Base and Competitors
Table 40. Amgen Major Business
Table 41. Amgen Non-prescription Drugs Product and Services
Table 42. Amgen Non-prescription Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021, 2022, 2023, and 2024)
Table 43. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 44. AstraZeneca Major Business
Table 45. AstraZeneca Non-prescription Drugs Product and Services
Table 46. AstraZeneca Non-prescription Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021, 2022, 2023, and 2024)
Table 47. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 48. Bristol-Myers Squibb Major Business
Table 49. Bristol-Myers Squibb Non-prescription Drugs Product and Services
Table 50. Bristol-Myers Squibb Non-prescription Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021, 2022, 2023, and 2024)
Table 51. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 52. Eli Lilly Major Business
Table 53. Eli Lilly Non-prescription Drugs Product and Services
Table 54. Eli Lilly Non-prescription Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021, 2022, 2023, and 2024)
Table 55. Teva Basic Information, Manufacturing Base and Competitors
Table 56. Teva Major Business
Table 57. Teva Non-prescription Drugs Product and Services
Table 58. Teva Non-prescription Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021, 2022, 2023, and 2024)
Table 59. Bayer Basic Information, Manufacturing Base and Competitors
Table 60. Bayer Major Business
Table 61. Bayer Non-prescription Drugs Product and Services
Table 62. Bayer Non-prescription Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021, 2022, 2023, and 2024)
Table 63. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 64. Novo Nordisk Major Business
Table 65. Novo Nordisk Non-prescription Drugs Product and Services
Table 66. Novo Nordisk Non-prescription Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021, 2022, 2023, and 2024)
Table 67. Allergan Basic Information, Manufacturing Base and Competitors
Table 68. Allergan Major Business
Table 69. Allergan Non-prescription Drugs Product and Services
Table 70. Allergan Non-prescription Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021, 2022, 2023, and 2024)
Table 71. Takeda Basic Information, Manufacturing Base and Competitors
Table 72. Takeda Major Business
Table 73. Takeda Non-prescription Drugs Product and Services
Table 74. Takeda Non-prescription Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021, 2022, 2023, and 2024)
Table 75. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 76. Boehringer Ingelheim Major Business
Table 77. Boehringer Ingelheim Non-prescription Drugs Product and Services
Table 78. Boehringer Ingelheim Non-prescription Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021, 2022, 2023, and 2024)
Table 79. Takeda Basic Information, Manufacturing Base and Competitors
Table 80. Takeda Major Business
Table 81. Takeda Non-prescription Drugs Product and Services
Table 82. Takeda Non-prescription Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021, 2022, 2023, and 2024)
Table 83. Global Non-prescription Drugs Sales by Manufacturer (2021, 2022, 2023, and 2024) & (K Units)
Table 84. Global Non-prescription Drugs Revenue by Manufacturer (2021, 2022, 2023, and 2024) & (USD Million)
Table 85. Market Position of Manufacturers in Non-prescription Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 86. Global Non-prescription Drugs Production Capacity by Company, (K Units): 2023 VS 2024
Table 87. Head Office and Non-prescription Drugs Production Site of Key Manufacturer
Table 88. Non-prescription Drugs New Entrant and Capacity Expansion Plans
Table 89. Non-prescription Drugs Mergers & Acquisitions in the Past Five Years
Table 90. Global Non-prescription Drugs Sales by Region (2020-2024) & (K Units)
Table 91. Global Non-prescription Drugs Sales by Region (2025-2031) & (K Units)
Table 92. Global Non-prescription Drugs Revenue by Region (2020-2024) & (USD Million)
Table 93. Global Non-prescription Drugs Revenue by Region (2025-2031) & (USD Million)
Table 94. Global Non-prescription Drugs Sales by Type (2020-2024) & (K Units)
Table 95. Global Non-prescription Drugs Sales by Type (2025-2031) & (K Units)
Table 96. Global Non-prescription Drugs Revenue by Type (2020-2024) & (USD Million)
Table 97. Global Non-prescription Drugs Revenue by Type (2025-2031) & (USD Million)
Table 98. Global Non-prescription Drugs Price by Type (2020-2024) & (USD/Unit)
Table 99. Global Non-prescription Drugs Price by Type (2025-2031) & (USD/Unit)
Table 100. Global Non-prescription Drugs Sales by Application (2020-2024) & (K Units)
Table 101. Global Non-prescription Drugs Sales by Application (2025-2031) & (K Units)
Table 102. Global Non-prescription Drugs Revenue by Application (2020-2024) & (USD Million)
Table 103. Global Non-prescription Drugs Revenue by Application (2025-2031) & (USD Million)
Table 104. Global Non-prescription Drugs Price by Application (2020-2024) & (USD/Unit)
Table 105. Global Non-prescription Drugs Price by Application (2025-2031) & (USD/Unit)
Table 106. North America Non-prescription Drugs Sales by Country (2020-2024) & (K Units)
Table 107. North America Non-prescription Drugs Sales by Country (2025-2031) & (K Units)
Table 108. North America Non-prescription Drugs Revenue by Country (2020-2024) & (USD Million)
Table 109. North America Non-prescription Drugs Revenue by Country (2025-2031) & (USD Million)
Table 110. North America Non-prescription Drugs Sales by Type (2020-2024) & (K Units)
Table 111. North America Non-prescription Drugs Sales by Type (2025-2031) & (K Units)
Table 112. North America Non-prescription Drugs Sales by Application (2020-2024) & (K Units)
Table 113. North America Non-prescription Drugs Sales by Application (2025-2031) & (K Units)
Table 114. Europe Non-prescription Drugs Sales by Country (2020-2024) & (K Units)
Table 115. Europe Non-prescription Drugs Sales by Country (2025-2031) & (K Units)
Table 116. Europe Non-prescription Drugs Revenue by Country (2020-2024) & (USD Million)
Table 117. Europe Non-prescription Drugs Revenue by Country (2025-2031) & (USD Million)
Table 118. Europe Non-prescription Drugs Sales by Type (2020-2024) & (K Units)
Table 119. Europe Non-prescription Drugs Sales by Type (2025-2031) & (K Units)
Table 120. Europe Non-prescription Drugs Sales by Application (2020-2024) & (K Units)
Table 121. Europe Non-prescription Drugs Sales by Application (2025-2031) & (K Units)
Table 122. Asia-Pacific Non-prescription Drugs Sales by Region (2020-2024) & (K Units)
Table 123. Asia-Pacific Non-prescription Drugs Sales by Region (2025-2031) & (K Units)
Table 124. Asia-Pacific Non-prescription Drugs Revenue by Region (2020-2024) & (USD Million)
Table 125. Asia-Pacific Non-prescription Drugs Revenue by Region (2025-2031) & (USD Million)
Table 126. Asia-Pacific Non-prescription Drugs Sales by Type (2020-2024) & (K Units)
Table 127. Asia-Pacific Non-prescription Drugs Sales by Type (2025-2031) & (K Units)
Table 128. Asia-Pacific Non-prescription Drugs Sales by Application (2020-2024) & (K Units)
Table 129. Asia-Pacific Non-prescription Drugs Sales by Application (2025-2031) & (K Units)
Table 130. South America Non-prescription Drugs Sales by Country (2020-2024) & (K Units)
Table 131. South America Non-prescription Drugs Sales by Country (2025-2031) & (K Units)
Table 132. South America Non-prescription Drugs Revenue by Country (2020-2024) & (USD Million)
Table 133. South America Non-prescription Drugs Revenue by Country (2025-2031) & (USD Million)
Table 134. South America Non-prescription Drugs Sales by Type (2020-2024) & (K Units)
Table 135. South America Non-prescription Drugs Sales by Type (2025-2031) & (K Units)
Table 136. South America Non-prescription Drugs Sales by Application (2020-2024) & (K Units)
Table 137. South America Non-prescription Drugs Sales by Application (2025-2031) & (K Units)
Table 138. Middle East & Africa Non-prescription Drugs Sales by Region (2020-2024) & (K Units)
Table 139. Middle East & Africa Non-prescription Drugs Sales by Region (2025-2031) & (K Units)
Table 140. Middle East & Africa Non-prescription Drugs Revenue by Region (2020-2024) & (USD Million)
Table 141. Middle East & Africa Non-prescription Drugs Revenue by Region (2025-2031) & (USD Million)
Table 142. Middle East & Africa Non-prescription Drugs Sales by Type (2020-2024) & (K Units)
Table 143. Middle East & Africa Non-prescription Drugs Sales by Type (2025-2031) & (K Units)
Table 144. Middle East & Africa Non-prescription Drugs Sales by Application (2020-2024) & (K Units)
Table 145. Middle East & Africa Non-prescription Drugs Sales by Application (2025-2031) & (K Units)
Table 146. Non-prescription Drugs Raw Material
Table 147. Key Manufacturers of Non-prescription Drugs Raw Materials
Table 148. Direct Channel Pros & Cons
Table 149. Indirect Channel Pros & Cons
Table 150. Non-prescription Drugs Typical Distributors
Table 151. Non-prescription Drugs Typical Customers
List of Figures
Figure 1. Non-prescription Drugs Picture
Figure 2. Global Non-prescription Drugs Revenue Market Share by Type in 2024
Figure 3. Brand Drugs
Figure 4. Generic Drug
Figure 5. Global Non-prescription Drugs Revenue Market Share by Application in 2024
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Other
Figure 9. Global Non-prescription Drugs Revenue, (USD Million) & (K Units): 2020 & 2024 & 2031
Figure 10. Global Non-prescription Drugs Revenue and Forecast (2020-2031) & (USD Million)
Figure 11. Global Non-prescription Drugs Sales (2020-2031) & (K Units)
Figure 12. Global Non-prescription Drugs Price (2020-2031) & (USD/Unit)
Figure 13. Global Non-prescription Drugs Production Capacity (2020-2031) & (K Units)
Figure 14. Global Non-prescription Drugs Production Capacity by Geographic Region: 2024 VS 2031
Figure 15. Non-prescription Drugs Market Drivers
Figure 16. Non-prescription Drugs Market Restraints
Figure 17. Non-prescription Drugs Market Trends
Figure 18. Global Non-prescription Drugs Sales Market Share by Manufacturer in 2024
Figure 19. Global Non-prescription Drugs Revenue Market Share by Manufacturer in 2024
Figure 20. Non-prescription Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2024
Figure 21. Top 3 Non-prescription Drugs Manufacturer (Revenue) Market Share in 2024
Figure 22. Top 6 Non-prescription Drugs Manufacturer (Revenue) Market Share in 2024
Figure 23. Global Non-prescription Drugs Sales Market Share by Region (2020-2031)
Figure 24. Global Non-prescription Drugs Revenue Market Share by Region (2020-2031)
Figure 25. North America Non-prescription Drugs Revenue (2020-2031) & (USD Million)
Figure 26. Europe Non-prescription Drugs Revenue (2020-2031) & (USD Million)
Figure 27. Asia-Pacific Non-prescription Drugs Revenue (2020-2031) & (USD Million)
Figure 28. South America Non-prescription Drugs Revenue (2020-2031) & (USD Million)
Figure 29. Middle East & Africa Non-prescription Drugs Revenue (2020-2031) & (USD Million)
Figure 30. Global Non-prescription Drugs Sales Market Share by Type (2020-2031)
Figure 31. Global Non-prescription Drugs Revenue Market Share by Type (2020-2031)
Figure 32. Global Non-prescription Drugs Price by Type (2020-2031) & (USD/Unit)
Figure 33. Global Non-prescription Drugs Sales Market Share by Application (2020-2031)
Figure 34. Global Non-prescription Drugs Revenue Market Share by Application (2020-2031)
Figure 35. Global Non-prescription Drugs Price by Application (2020-2031) & (USD/Unit)
Figure 36. North America Non-prescription Drugs Sales Market Share by Type (2020-2031)
Figure 37. North America Non-prescription Drugs Sales Market Share by Application (2020-2031)
Figure 38. North America Non-prescription Drugs Sales Market Share by Country (2020-2031)
Figure 39. North America Non-prescription Drugs Revenue Market Share by Country (2020-2031)
Figure 40. United States Non-prescription Drugs Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 41. Canada Non-prescription Drugs Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 42. Mexico Non-prescription Drugs Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 43. Europe Non-prescription Drugs Sales Market Share by Type (2020-2031)
Figure 44. Europe Non-prescription Drugs Sales Market Share by Application (2020-2031)
Figure 45. Europe Non-prescription Drugs Sales Market Share by Country (2020-2031)
Figure 46. Europe Non-prescription Drugs Revenue Market Share by Country (2020-2031)
Figure 47. Germany Non-prescription Drugs Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 48. France Non-prescription Drugs Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 49. United Kingdom Non-prescription Drugs Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 50. Russia Non-prescription Drugs Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 51. Italy Non-prescription Drugs Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 52. Asia-Pacific Non-prescription Drugs Sales Market Share by Region (2020-2031)
Figure 53. Asia-Pacific Non-prescription Drugs Sales Market Share by Application (2020-2031)
Figure 54. Asia-Pacific Non-prescription Drugs Sales Market Share by Region (2020-2031)
Figure 55. Asia-Pacific Non-prescription Drugs Revenue Market Share by Region (2020-2031)
Figure 56. China Non-prescription Drugs Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 57. Japan Non-prescription Drugs Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 58. Korea Non-prescription Drugs Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 59. India Non-prescription Drugs Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 60. Southeast Asia Non-prescription Drugs Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 61. Australia Non-prescription Drugs Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 62. South America Non-prescription Drugs Sales Market Share by Type (2020-2031)
Figure 63. South America Non-prescription Drugs Sales Market Share by Application (2020-2031)
Figure 64. South America Non-prescription Drugs Sales Market Share by Country (2020-2031)
Figure 65. South America Non-prescription Drugs Revenue Market Share by Country (2020-2031)
Figure 66. Brazil Non-prescription Drugs Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 67. Argentina Non-prescription Drugs Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 68. Middle East & Africa Non-prescription Drugs Sales Market Share by Type (2020-2031)
Figure 69. Middle East & Africa Non-prescription Drugs Sales Market Share by Application (2020-2031)
Figure 70. Middle East & Africa Non-prescription Drugs Sales Market Share by Region (2020-2031)
Figure 71. Middle East & Africa Non-prescription Drugs Revenue Market Share by Region (2020-2031)
Figure 72. Turkey Non-prescription Drugs Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 73. Egypt Non-prescription Drugs Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 74. Saudi Arabia Non-prescription Drugs Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 75. South Africa Non-prescription Drugs Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Non-prescription Drugs in 2024
Figure 77. Manufacturing Process Analysis of Non-prescription Drugs
Figure 78. Non-prescription Drugs Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 医薬品の世界市場2025年：先発医薬品、ジェネリック医薬品
  • リツキシマブ注射のグローバル市場2023：先発医薬品、ジェネリック医薬品
  • バルプロ酸ナトリウムSR錠のグローバル市場2023：先発医薬品、ジェネリック医薬品
  • ドロネダロン塩酸塩錠の世界市場2023-2029：先発医薬品、ジェネリック医薬品
  • インスリンアスパルト30注射液の世界市場2023-2029：先発医薬品、ジェネリック医薬品
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22DC3872 )"一般用医薬品の世界市場2025年：先発医薬品、ジェネリック医薬品" (英文：Global Non-prescription Drugs Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。